Randomised phase II study of epirubicin-vindesine versus mitoxantrone-vindesine in metastatic breast cancer
- 1 December 1995
- journal article
- clinical trial
- Published by Elsevier in European Journal Of Cancer
- Vol. 31 (13-14) , 2169-2173
- https://doi.org/10.1016/0959-8049(95)00489-0
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Chemotherapy for Advanced DiseaseChest, 1996
- Dose effect relationship in breast cancerAnnals of Oncology, 1993
- Diverse prognosis in metastatic breast cancer: Who should be offered alternative initial therapies?Breast Cancer Research and Treatment, 1989
- Evaluation of mitoxantrone cardiac toxicity by nuclear angiography and endomyocardial biopsy: an updateInvestigational New Drugs, 1985
- A comparison of intermittent vs. continuous and of adriamycin vs. methotrexate 5-drug chemotherapy for advanced breast cancer A Cancer and Leukemia Group B studyAmerican Journal of Clinical Oncology, 1984
- A comparison of cyclophosphamide, adriamycin, and 5-fluorouracil (CAF) and cyclophosphamide, methotrexate, 5-fluorouracil, vincristine, and prednisone (CMFVP) in patients with advanced breast cancerBreast Cancer Research and Treatment, 1983
- An Algorithm for Finding the Exact Significance Levels of r × c Contingency TablesJournal of the American Statistical Association, 1981
- Reporting results of cancer treatmentCancer, 1981
- Assessment of response to therapy in advanced breast cancerPublished by Elsevier ,1977
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958